KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Payables (2016 - 2025)

Historic Payables for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Quest Diagnostics' Payables rose 1096.73% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1096.73%. This contributed to the annual value of $1.4 billion for FY2024, which is 257.54% up from last year.
  • Per Quest Diagnostics' latest filing, its Payables stood at $1.5 billion for Q3 2025, which was up 1096.73% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Payables registered a high of $1.6 billion during Q3 2021, and its lowest value of $1.2 billion during Q3 2023.
  • For the 5-year period, Quest Diagnostics' Payables averaged around $1.4 billion, with its median value being $1.4 billion (2024).
  • As far as peak fluctuations go, Quest Diagnostics' Payables soared by 5891.95% in 2021, and later tumbled by 2240.93% in 2023.
  • Quest Diagnostics' Payables (Quarter) stood at $1.6 billion in 2021, then decreased by 12.75% to $1.4 billion in 2022, then decreased by 2.65% to $1.4 billion in 2023, then grew by 2.58% to $1.4 billion in 2024, then rose by 4.52% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.